MedPath

A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis

Phase 4
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Hydrogel vehicle
Registration Number
NCT01065714
Lead Sponsor
Derm Research, PLLC
Brief Summary

While the repair of the epidermal barrier in atopic dermatitis is of major importance in the treatment of atopic dermatitis, most of the vehicles used may actually cause a worsening of an impaired epidermal barrier. Hydrogel vehicle is anecdotally known to be moisturizing and hydrating.This study will compare the use of Hydrogel vehicle and Eucerin Lotion in maintaining the epidermal barrier in subjects with atopic dermatitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Definitive diagnosis of atopic dermatitis as characterized by Hanifin and Rajka criteria:
  • 3 out of 4 major characteristics
  • At least 3 minor characteristics
  • Mild to moderate disease score of 2 or 3 by Investigator Global Assessment
  • Minimum 5% Body Surface Area at Baseline
  • Uniformly bilateral signs and symptoms of atopic dermatitis
  • Able to understand and comply with the requirements of the study and sign Informed Consent/HIPAA forms. Subjects under the legal age of consent must also have written informed consent of the parent or legal guardian.
Exclusion Criteria
  • Allergy or sensitivity to any component of the test articles.
  • Subjects who have not complied with the proper washout periods for prohibited medications.
  • Significant coagulation disorder or any medical condition that, in the opinion of the investigator, contraindicates the subject's participation in the study.
  • Recent alcohol or drug abuse is evident.
  • History of poor cooperation, non-compliance with medical treatment or unreliability
  • Participation in an investigational drug study within 30 days of the Baseline Visit.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Eucerin LotionEucerin LotionParallel study design. Split body study.
Hydrogel vehicleHydrogel vehicleParallel designed study. Split body treatment
Primary Outcome Measures
NameTimeMethod
Percent Change of Trans Epidermal Water Loss (TEWL) With Use of Eucerin LotionDay 1 to Day 14

The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on targeted area of body half treated with Eucerin lotion

Percent Change of Trans Epidural Water Loss (TEWL) With the Use of Hydrogel VehicleDay 1 to Day 14

The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on target areas of body half treated with Hydrogel vehicle

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants With an Increase in Skin Hydration Using Eucerin Lotion on Targeted Area on One Half of BodyBaseline to 14 days

Five timed readings ( 0, 15, 30, 45 and 60 minutes) were taken using the Corneometer 825 meter on subjects using Eucerin lotion on targeted area on one half of body

Percentage of Participants With an Increase in Skin Hydration Using Hydrogel Vehicle on Targeted Area of One Half of Body.Baseline to 14 days

Five timed readings at (0, 15, 30, 45 and 60 minutes) were taken, using the Corneometer 825 meter, on participants using Hydrogel vehicle

Trial Locations

Locations (1)

DermResearch, PLLC

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath